Back to top

Image: Bigstock

UPS Beats on Q4 Earnings

Read MoreHide Full Article

United Parcel Service (UPS - Free Report) reported fourth-quarter 2019 earnings per share (on an adjusted basis) of $2.11 per share, surpassing the Zacks Consensus Estimate by a penny. Earnings increased on a year-over-year basis.

How Was the Estimate Revision Trend?

Investors should note that the earnings estimate revisions for UPS depicted a stable picture prior to the earnings release. The Zacks Consensus Estimate for fourth-quarter earnings remained stagnant over the past 60 days

Prior to the earnings beat in the fourth-quarter, the company delivered positive surprises in three of the last four quarters. The average earnings beat was 0.4%.

United Parcel Service, Inc. Price and EPS Surprise

 

United Parcel Service, Inc. Price and EPS Surprise

United Parcel Service, Inc. price-eps-surprise | United Parcel Service, Inc. Quote

Revenues LowerThan Expected

UPS recorded operating revenues of $20,568 million, which missed the Zacks Consensus Estimate of $20,578.5 million. Revenues, however, increased year over year.

Key Stats to Note: The package delivery company expects 2020 adjusted earnings per share between $7.76 and $8.06. The Zacks Consensus Estimate for 2019 currently stands at $7.98 per share. Adjusted free cash flow is expected to be between $4.3 billion and $4.7 billion for the current year. Effective tax rate is expected between 22.5% and 23.5% for 2020.

Zacks Rank: Currently, UPS carries a Zacks Rank #3 (Hold) which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank stocks here.

Check back later for our full write up on this UPS earnings report later!

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

 


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


United Parcel Service, Inc. (UPS) - free report >>